Coaching for Chronic Pain and Depression
(EQUIPD Trial)
Trial Summary
What is the purpose of this trial?
This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients with comorbid chronic pain and depression, to encourage use of and adherence to nonpharmacological pain treatments (NPTs). This 2-arm trial will randomize 304 patients with comorbid chronic musculoskeletal pain and depression in primary care from an urban safety-net health system (Eskenazi). After the baseline assessment, patients randomized to the intervention will be asked to participate in 4 coaching sessions over approximately 12 weeks. Sessions will use Motivational Interviewing principles to foster openness to NPTs and self-efficacy by helping patients identify their goals and priorities, understand their NPT options, prepare them to discuss and choose options with their primary care providers (PCPs), and reinforce these choices to foster maintenance of these changes. DA contents will be integrated into these sessions, which will facilitate discussion of these options with their PCP. The first 3 sessions take place prior to the patient's next scheduled PCP visit; the final session occurs after this visit. Assessments will be conducted at baseline, 3 months (i.e., after completing the final coaching session), and 6 months. Patients randomized to the wait-list control group will receive usual care (in addition to study assessments at baseline, 3 months, and 6 months). After completing the final assessment, they will then be given the DA and offered a 20-minute coaching session to walk them through it.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on encouraging non-drug treatments for pain, but it doesn't mention a requirement to stop existing medications.
What data supports the idea that Coaching for Chronic Pain and Depression is an effective treatment?
The available research shows that Coaching for Chronic Pain and Depression, which includes techniques like motivational interviewing, is effective in helping people manage their pain and improve their mental health. One study found that motivational interviewing helped patients change their attitudes and behaviors, which is important for managing chronic pain. Another study showed that a peer coaching program helped veterans manage their pain better by providing support and advice from others who have successfully managed their own pain. These studies suggest that this treatment can help people feel more in control of their pain and improve their quality of life.12345
What safety data exists for coaching treatments for chronic pain and depression?
The available research suggests that motivational interviewing and similar coaching methods, such as decision aid coaching and nonpharmacological pain treatment coaching, are generally focused on improving patient engagement and readiness to manage chronic pain. These methods emphasize patient-centered discussions and shared decision-making, which can help reduce the risks associated with long-term opioid therapy by promoting non-opioid based treatment options. While specific safety data is not detailed in the provided research, these approaches are designed to empower patients and improve psychosocial function, suggesting a low risk of harm when used appropriately.16789
Is the treatment Coaching, Decision Aid a promising treatment for chronic pain and depression?
Yes, Coaching, Decision Aid is a promising treatment for chronic pain and depression. It uses motivational interviewing to help people change their attitudes and behaviors, which can improve their ability to manage pain and enhance their quality of life. This approach can make patients more ready and motivated to stick with their treatment plans, potentially leading to better outcomes.125710
Research Team
Marianne Matthias, PHd
Principal Investigator
Indiana University
Eligibility Criteria
This trial is for Black patients with both chronic musculoskeletal pain and depression. Participants will be from an urban safety-net health system and must not have started any nonpharmacological pain treatments (NPTs) before the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of participants' conditions before randomization
Treatment
Participants in the intervention group receive 4 coaching sessions over 12 weeks using Motivational Interviewing principles
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 3 and 6 months
Treatment Details
Interventions
- Coaching (Behavioral Intervention)
- Decision Aid (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Alan Palkowitz
Indiana University
Chief Executive Officer since 2020
PhD in Chemistry from Indiana University
David Ingram
Indiana University
Chief Medical Officer since 2020
MD from Indiana University School of Medicine
National Institute of Nursing Research (NINR)
Collaborator
Dr. Jessica Gill
National Institute of Nursing Research (NINR)
Chief Medical Officer since 2023
PhD in Nursing from Johns Hopkins University
Dr. Shannon Zenk
National Institute of Nursing Research (NINR)
Chief Executive Officer since 2020
PhD in Urban Planning and Policy Development from Rutgers University